MEDIA

Giandomenico Ricci/Flickr


The best and worst celebrity pharma moments

The best and worst celebrity pharma moments

We present to you our picks for the best and worst moments in celebrity healthcare spokespersonship—plus a few more that, frankly, we can't find anywhere.

Celebrity drug ads: Opportunity or PR disaster?

Celebrity drug ads: Opportunity or PR disaster?

Tapping celebrities for brand or awareness campaigns ensures a high degree of attention, but such arrangements come with concerns that "regular" ones do not.

Is This the End of Agency Diversification?

Is This the End of Agency Diversification?

DTC and OTC/wellness can borrow from mainstream consumer shops. Professional marketing may pose a tougher sell.

BMS CEO defends use of DTC to promote cancer drug

BMS CEO defends use of DTC to promote cancer drug

The drugmaker's CEO said the campaign helps dispel pessimism created from a history of cancer drugs that lack "significant value."

Marketers Rely on Email and Social Media, Rather than Face Time

Marketers Rely on Email and Social Media, Rather than Face Time

Curating personal relationships is one of the most valuable functions medical marketers can provide. The best way is through face-to-face interaction.

Five things for pharma marketers to know: Wednesday, January 27, 2016

Five things for pharma marketers to know: Wednesday, January 27, 2016

The FDA plans to release new guidance on advertising in 2016; Trump supports Medicare price negotiations; Novartis CEO: golden days of drug pricing are over

Medical publishers eye new ad viewability rules

Medical publishers eye new ad viewability rules

They will attempt to develop a new industry standard for digital advertising viewability, a much debated topic that has vexed the broader advertising industry.

What the AMA's Proposed DTC Ban Overlooks

What the AMA's Proposed DTC Ban Overlooks

While DTC advertising does significantly impact consumer demand, most evidence suggests the majority of this demand benefits the overall state of consumer health.

Pharma companies turn to LinkedIn to engage

Pharma companies turn to LinkedIn to engage

Part of LinkedIn's appeal lies in the high level of engagement of its members and the potential for precise targeting of content and talent searches.

Healthline Media receives $95 million in equity funding

Healthline Media receives $95 million in equity funding

Summit Partners' investment in the health information site expected to aid the company's efforts to compete with sites like WebMD